AlzeCure Pharma

AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in innovative drug research, primarily focusing on Alzheimer's disease. The company is listed on the Nasdaq First North Premier Growth Market and is developing five drug candidates based on two research platforms, NeuroRestore and Alzstatin.